Weight Loss10 min read·Published October 23, 2026

How to Lose Weight in Perimenopause: What Helps and When Medication May Fit

A practical, evidence-based guide to food, strength training, sleep, medical screening, and prescription options.

How to Lose Weight in Perimenopause: What Helps and When Medication May Fit

To lose weight in perimenopause, focus on habits that protect muscle and support a sustainable calorie deficit: mostly minimally processed foods, protein and fiber, strength training, daily movement, and better sleep. It is also worth checking for health issues that can affect weight. Prescription medication may be appropriate for some people after clinician review. 3 4 5

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

Why does weight loss feel harder in perimenopause?

Perimenopause is the years before menopause, when menstrual cycles become less predictable and symptoms such as hot flashes or sleep disruption can begin. It often starts in the 40s, though timing varies widely. These changes can make familiar routines harder to sustain, but they do not make weight loss impossible. 1

What changes during the menopause transition?

Weight and waist size can change during midlife for several reasons at once: aging, reduced activity, changes in lean muscle mass, sleep disturbance, genetics, eating patterns, and shifting ovarian hormones. Estrogen changes may contribute to a greater tendency toward central adiposity, meaning fat stored around the abdomen, but they are not the only cause. 1 2

Why body composition matters as much as the scale

Lean muscle mass tends to decline with age unless it is actively maintained. A person may notice a smaller waist-to-hip change, less strength, or clothing fitting differently even if body weight has not changed much. That is why resistance exercise, enough food quality, and realistic goals matter alongside the number on the scale. 2 3

What actually helps with perimenopause weight loss?

The most useful approach is usually not a menopause-specific diet. A sustainable reduced-calorie eating pattern plus regular activity remains the core approach for weight management, with changes tailored to health history, food access, symptoms, and preferences. 4 5

Build meals around protein, fiber, and minimally processed foods

A Mediterranean-style pattern can be a practical starting point: vegetables and fruit, beans, whole grains, nuts, unsaturated fats, and protein-rich foods. Protein supports muscle maintenance, while dietary fiber can help fullness and support blood sugar and heart health. There is no single food or supplement proven to cause perimenopause weight loss on its own. 4 5

Rather than crash dieting, consider noticing the foods and situations that make it easy to eat past fullness: large portions, sugary drinks, frequent alcohol, low-fiber snacks, skipped meals followed by intense hunger, or poor sleep. A registered dietitian can help adapt this approach around diabetes, kidney disease, digestive conditions, cultural foods, or a history of disordered eating. 4 5

Use strength training and cardio for different benefits

Muscle-strengthening activity at least 2 days per week is part of the U.S. physical activity guidance for adults. Strength training helps maintain or build muscle, while aerobic movement supports cardiovascular health. Walking, cycling, swimming, and other activities can count; the best plan is one that fits your joints, schedule, and current fitness. 3

If you are new to exercise, have joint pain, chest symptoms, dizziness, or a condition that affects safe movement, ask a clinician or qualified physical therapist how to begin. Increasing daily non-exercise movement, such as short walks or standing breaks, can also make activity more manageable. 3

How can you flatten a perimenopause belly?

There is no exercise or food that selectively removes belly fat. Spot reduction does not work, but overall fat loss, strength training, regular movement, sleep support, and less alcohol can improve waist size and cardiometabolic health over time. 2 3 5

Abdominal fat includes subcutaneous fat under the skin and visceral fat around internal organs. A growing waist can be a reason to discuss blood pressure, cholesterol, A1c or fasting glucose, liver health, and other cardiovascular risk factors with a clinician. These tests do not diagnose every cause of weight change, but they can guide a more complete plan. 2

Do popular rules like 30/30/30 or 3-3-3 help?

Popular rules can be useful reminders, but no named rule is proven specifically for perimenopause weight loss. The 30/30/30 rule commonly means eating 30 grams of protein within 30 minutes of waking, then doing 30 minutes of low-intensity exercise. The meaning of “3-3-3” varies online, so it is not a standardized medical method. 4 5

The helpful parts are usually the basics: include protein-rich foods, move regularly, and build routines you can repeat. The less helpful part is treating a social-media rule as a requirement or assuming it works for every medical history. There is no need to force an early meal, restrict foods severely, or follow a rigid schedule to support weight management. 4 5

SituationSensible next stepWhy it may help
Weight has changed slowly, with no concerning symptomsReview meals, activity, sleep, alcohol, and stress patterns; choose one or two sustainable changesLifestyle treatment remains the foundation of weight management. 4 5
Waist size is increasing or there is a family history of diabetesDiscuss blood pressure, lipids, glucose or A1c, and liver health with a clinicianScreening can identify cardiometabolic risks that may change the care plan. 2
Hot flashes or poor sleep are affecting daily routinesDiscuss menopause symptoms and sleep with a licensed clinicianSymptom treatment may improve quality of life and make healthy routines easier to maintain. 1
Obesity or weight-related health risks persist despite lifestyle effortsAsk whether prescription weight-management treatment is appropriateMedication eligibility, risks, and alternatives require an individual medical review. 6 7
Rapid change, severe fatigue, or other new symptomsArrange a timely clinical evaluationWeight change can have medical contributors beyond menopause. 2

3-min quiz

Talk through your weight and menopause goals

Our licensed providers can review your health history, symptoms, and whether a prescription option may be clinically appropriate. A prescription requires a medical evaluation and is never guaranteed. Chia medications are compounded by state-licensed US 503A pharmacies and are not FDA-approved.

Does perimenopausal weight gain go away?

Weight may stabilize for some people after the menopause transition, but waist size and body composition can still need attention over time. Aging-related muscle loss and changes in daily activity do not automatically reverse after periods stop, so it is reasonable to focus on strength, mobility, sleep, blood pressure, and energy—not only the scale. 2 3

A realistic goal may be better stamina, improved strength, a smaller waist measurement, improved blood sugar markers, or habits that feel easier to keep. If bone health is a concern, avoid aggressive dieting without clinical context; bone changes can occur across the menopause transition. 11

When should you ask about medical causes or treatment options?

It is reasonable to ask for help when weight change comes with new symptoms or health risks, or when consistent lifestyle efforts have not matched your goals. A clinician may review medications, blood pressure, glucose or A1c, lipids, thyroid symptoms and testing when indicated, liver health, mood, sleep, and menopause symptoms. 2

Prescription weight-management medications are not right for everyone. Semaglutide is a GLP-1 receptor agonist; Wegovy is an FDA-approved semaglutide product for chronic weight management, while Ozempic is approved for type 2 diabetes. Tirzepatide is a GIP/GLP-1 receptor agonist; Zepbound is approved for chronic weight management, while Mounjaro is approved for type 2 diabetes. 6 7 9 10

In the STEP 1 trial, adults with overweight or obesity received semaglutide 2.4 mg once weekly alongside lifestyle intervention and had greater average weight loss than the placebo group at 68 weeks. In SURMOUNT-1, adults with obesity or overweight received tirzepatide once weekly and had greater average weight loss than placebo at 72 weeks. These trials were not specific to people in perimenopause, and individual results vary. 12 13

Both active ingredients can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and abdominal pain. FDA labels also include important warnings and contraindications, including a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 for these medicines. A clinician should review pregnancy plans, gallbladder or pancreas history, kidney concerns, other medicines, and your full health history. 6 7 9 10

How do GLP-1 options at Chia fit into perimenopause weight concerns?

At Chia, we start with an online health questionnaire and a licensed US provider’s review. For people who may qualify, we offer compounded semaglutide as an injection and compounded tirzepatide as tablets or injections. These compounded treatments are not FDA-approved, and both treatments have provider-guided dosing; microdosing plans are available when a provider determines they are appropriate. 8

Our providers consider weight-related health risks, symptoms, medications, and safety concerns—not just a number on the scale. If prescribed, medication is compounded in the US by a state-licensed 503A pharmacy and shipped to your door, with portal access for care-team messages. Compounded drugs are not FDA-approved, and a prescription is never guaranteed. FDA notes that compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. 8

Chia optionAvailable formWhat to know
Compounded semaglutideInjection; plans currently start at $249/moA provider reviews whether it fits your health history. This compounded medication is not FDA-approved. Microdosing plans are available when clinically appropriate. 6 8
Compounded tirzepatideTablets from $249/mo; injection from $299/moA provider can discuss form preference, medical history, and provider-guided dosing. This compounded medication is not FDA-approved. Microdosing plans are available when clinically appropriate. 7 8
Weight + EnergyNAD+ injection plus a choice of GLP-1; from $309/moThis is a Chia protocol and is not FDA-approved as a combination. Whether any component fits requires clinician review; it is not a substitute for nutrition, activity, or evaluation of symptoms. 8
Weight + MuscleSermorelin injection plus a choice of GLP-1; from $329/moThis is a Chia protocol and is not FDA-approved as a combination. A provider should assess goals, risks, and whether treatment is clinically appropriate. 8

For a fuller overview of medication categories, see our guide to prescription medications for weight loss. If appetite or persistent thoughts about food are part of the challenge, our explanation of GLP-1 food noise may also help put the experience into context.

How does HRT fit into perimenopause weight concerns?

Hormone replacement therapy, also called menopausal hormone therapy, is used to address certain menopause symptoms—not as a weight-loss treatment. HRT is not prescribed to cause weight loss. For some people, treating hot flashes or sleep disruption may improve quality of life and make daily health habits more manageable, but it should be evaluated separately from a weight-management plan. 1

At Chia, providers may discuss estradiol and progesterone when menopause symptoms and medical history make hormone treatment worth evaluating. Hormone therapy has benefits and risks that depend on the person, their symptoms, age, health history, and treatment details. It requires an individual clinician review. 1

If food changes feel confusing, our guide to a menopause diet for weight loss focuses on practical eating patterns rather than restrictive rules. Our article on weight loss after menopause explains how the transition can continue to affect body composition over time.

When should you get help now?

Seek urgent care for chest pain, severe shortness of breath, fainting, severe abdominal pain, repeated vomiting with inability to keep fluids down, or thoughts of self-harm. For nonurgent but concerning changes—such as rapid unexplained weight change, persistent exhaustion, heavy or unusual bleeding, severe mood symptoms, or signs of high blood sugar—contact a licensed clinician promptly. 1 2 6 7

3-min quiz

Start with a clinician-guided evaluation

If you are exploring whether a GLP-1 option fits your perimenopause weight concerns, our online visit begins with a licensed-provider review. A prescription is not guaranteed. Medications prescribed through Chia are compounded by state-licensed US 503A pharmacies and are not FDA-approved. See current details for semaglutide and tirzepatide.

FAQ: losing weight in perimenopause

References

  1. 1.National Institute on Aging. What Is Menopause? 2025.
  2. 2.National Institute of Diabetes and Digestive and Kidney Diseases. Factors Affecting Weight and Health. 2025.
  3. 3.U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. 2018.
  4. 4.U.S. Departments of Agriculture and Health and Human Services. Dietary Guidelines for Americans, 2020–2025. 2020.
  5. 5.Centers for Disease Control and Prevention. Steps for Losing Weight. 2025.
  6. 6.U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2024.
  7. 7.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. 2025.
  8. 8.U.S. Food and Drug Administration. Compounded Drugs. 2025.
  9. 9.U.S. Food and Drug Administration. Ozempic (semaglutide) prescribing information. 2025.
  10. 10.U.S. Food and Drug Administration. Mounjaro (tirzepatide) prescribing information. 2025.
  11. 11.Seifert-Klauss V, Fillenberg S, Schneider H, et al. Bone loss in premenopausal, perimenopausal and postmenopausal women: results of a prospective observational study over 9 years. Climacteric. 2012.
  12. 12.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
  13. 13.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides